HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

California Dreaming? Dems Re-Introduce Legislation To Regulate Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

Manufacturers of cosmetics subject to FDA regulation and sold in California would be required to report to the Department of Health Services any ingredient containing a chemical known to the state as causing cancer or reproductive toxicity under legislation pending in the state senate
Advertisement

Related Content

Cosmetics Industry Loses California Battle; Ingredient Bill Becomes Law
Cosmetics Industry Loses California Battle; Ingredient Bill Becomes Law
Calif. Cosmetics Bill Appears Headed To Governor’s Desk
Calif. Cosmetics Bill Appears Headed To Governor’s Desk
Calif. bills
Calif. bills
Calif. Phthalate Ban Defeated But Cosmetic Ingredient Bill Clears Cmte.
Calif. Phthalate Ban Defeated But Cosmetic Ingredient Bill Clears Cmte.
California legislation
California Health Groups To Sustain Push For Phthalates Ban In Cosmetics
Advertisement
UsernamePublicRestriction

Register

RS012937

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel